News

Cadence Partners with VEDP and BRCC for Job Starter Program

Cadence and several other local Shenandoah Valley, Virginia-based manufacturers are teaming up with the Virginia Economic Development Partnership (VEDP) and Blue Ridge Community College for their new Job Starter training program.  Job Starter is a paid training program that allows potential job candidates the opportunity to receive training and meet local employers during a 3-week period.  Ultimately, this program is intended to help members of the community land a career in the advanced manufacturing industry with the employer of their choice.

“It was a great experience to be part of the team of local employers that helped develop this program with Blue Ridge Community College and VEDP,” said Rachel Brown, Human Resources Manager at Cadence’s Virginia facility.  “I believe Job Starter will be an excellent resource for Shenandoah Valley residents that are interested in having a career in advanced manufacturing.”

Job Starter begins October 25 and runs through November 15.  Careers in the program include, but are not limited to, production associates, machine operators, and manufacturing apprentices.  Other local companies participating in the program are Berry Global, Daikin Applied, Dynamic Aviation, Innovative Refrigeration Systems, McKee Foods, and Provides US.

To learn more about Job Starter or to register for this inaugural program, please visit: https://www2.cadenceinc.com/BRCCjobstarter.

Recent News

05/14/2025

Civica to start Chesterfield lab construction this summer, eyes Petersburg plant expansion

Nearly three years after announcing plans to build a laboratory in Chesterfield to support its manufacturing operations in Petersburg, Civica Rx is readying plans to kick off the project’s construction. The Utah-based nonprofit drugmaker said it will break ground this summer on a 50,000-square-foot facility at 11731 Meadowville Lane, in the Meadowville Technology Park near Chester.

05/07/2025

Adial Pharmaceuticals raises $2.75M

Glen Allen biopharma company Adial Pharmaceuticals Inc. (NASDAQ: ADIL) has raised $2.75 million from an institutional investor. The company, which specializes in therapies for addiction and related disorders, said it will use the new funding for working capital and general corporate purposes. The name of the investor was not disclosed, but Adial said a “health

05/07/2025

Adovate Granted New U.S. Patent for Therapeutic Uses of A2B Receptor Antagonists

Adovate, LLC (“Adovate” or the “Company”), a biopharmaceutical company developing novel therapeutics targeting adenosine receptors involved in major diseases, today announced that Patent Number 12,269,828 B2 was issued by the United States Patent and Trademark Office. This newly issued patent covers therapeutic uses of the Company’s lead molecule ADO-5030 and thousands of other novel molecules